文献

J-GLOBAL ID：200902216607819267   整理番号：07A0622910

心不全患者治療中の酸化ストレス軽減に与えるA型ナトリウム利尿ペプチドの優れた効果

Predominant Effect of A-Type Natriuretic Peptide on Reduction of Oxidative Stress During the Treatment of Patients With Heart Failure

著者 (12件)： SHONO Makoto (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.) ,  YOSHIMURA Michihiro (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.) ,  NAKAYAMA Masafumi (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.) ,  YAMAMURO Megumi (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.) ,  ABE Koji (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.) ,  SUZUKI Satoru (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.) ,  MIZUNO Yuji (Div. of Cardiology, Kumamoto Aging Res. Inst.) ,  SUGIYAMA Seigo (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.) ,  SAITO Yoshihiko (First Dep. of Internal Medicine, Nara Medical Univ.) ,  NAKAO Kazuwa (Dep. of Medicine and Clinical Sci., Kyoto Univ. Graduate School of Medicine) ,  YASUE Hirofumi (Div. of Cardiology, Kumamoto Aging Res. Inst.) ,  OGAWA Hisao (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.)
資料名： Circulation Journal  (Circulation Journal)
巻： 71  号： 7  ページ： 1040-1046 (J-STAGE)  発行年： 2007年 
JST資料番号： F0908A  ISSN： 1346-9843  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 背景:酸化ストレスは,心不全の病因で重要な役割を果たし,この...

シソーラス用語： *心不全 ,...
準シソーラス用語： ROS

   続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0622910&from=J-GLOBAL&jstjournalNo=F0908A") }}

分類 (2件)： 心臓作用薬の臨床への応用  (GW07030Y) ,  循環系疾患の薬物療法  (GJ05020M)

物質索引 (2件)： カルペリチド(遺伝子組換え) ,  フロセミド

引用文献 (37件)：

• 1. Saito Y, Nakao K, Nishimura K, Sugawara A, Okumura K, Obata K, et al. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: Beneficial effects on left ventricular function. Circulation 1987; 76: 115-124.
• 2. Yoshimura M, Yasue H, Morita E, Sakaino N, Jogasaki M, Kuroe M, et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991; 84: 1581-1588.
• 3. Suwa M, Seino Y, Nomachi Y, Matsuki S, Funahashi K. Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the `real world' of therapy. Circ J 2005; 69: 283-290.
• 4. Vollmar AM. The role of atrial natriuretic peptide in the immune system. Peptides 2005; 26: 1086-1094.
• 5. Mallat Z, Philip I, Lebret M, Chatel D, Maclouf J, Tedgui A. Elevated levels of 8-iso-prostaglandin F2α in pericardial fluid of patients with heart failure: A potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 1998; 97: 1536-1539.

タイトルに関連する用語 (4件)： 心不全 ,  患者治療 ,  酸化ストレス ,  ナトリウム利尿ペプチド